jlk2144 at gmail.com
Mon Oct 7 17:57:59 CEST 2019
Thanks Giuseppe, Jerome, and Uwe. All of this makes sense to me. I will have to talk to our software and management people and decide what our best route is. Incidentally, we will also need FDA certification for this product. This is all a bit preliminary. The product is still in development. I’m in touch with the Qt office in Boston as well.
> On Oct 7, 2019, at 1:55 AM, Uwe Rathmann <Uwe.Rathmann at tigertal.de> wrote:
>> On 10/6/19 12:03 PM, Giuseppe D'Angelo via Interest wrote:
>> Hey, I linked it two emails ago :-)
> Ah yes, sorry.
> My response was initially more explicit about FUD, before I decided, that it is not worth the effort.
More information about the Interest